Agent Trial
Trading Prediction Markets AI Agent Context Fastest News API Agent Trial Log In Sign Up
News Wire / health

Cancer Patients Show Robust Immune Response Post-Vaccine

Bluesky Social 1h Impact 5
Researchers found that patients whose cancers did not return also had the most robust immune response post-vaccine. This suggests the vaccine boosted recurrence-free survival over five years.

Topics

cancer vaccines immunology

Developing

  1. 884d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
  2. 884d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
  3. 884d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
  4. 884d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.

Sources · 7 independent

Bluesky Social

“Researchers found that people whose cancers did not return also had the most robust immune response post-vaccine, suggesting it is the vaccine that boosted recurrence-free survival over five years.”

Unlock the full story

Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.

Log in to upgrade